Trial NCT00560352

View at ClinicalTrials.gov 
Org. Study IDs: CA180-181

Last trial update was posted on 2017-03-13

MeSH Interventions

Bortezomib Dasatinib Dexamethasone

MeSH Conditions

Multiple Myeloma Neoplasms, Plasma Cell

Other Conditions


Stopping Reasons

N/A

Limitations And Caveats

The study was terminated due to an unexpectedly low recruitment rate, and no participants were enrolled in a planned dose-expansion phase.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID